Mark Sheptoff Financial Planning LLC lowered its position in The Clorox Company (NYSE:CLX – Free Report) by 3.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 4,900 shares of the company’s stock after selling 200 shares during the period. Mark Sheptoff Financial Planning LLC’s holdings in Clorox were worth $796,000 at the end of the most recent reporting period.
A number of other large investors also recently made changes to their positions in CLX. Brooklyn Investment Group boosted its stake in shares of Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock worth $25,000 after buying an additional 95 shares during the last quarter. Continuum Advisory LLC boosted its position in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares during the last quarter. Millstone Evans Group LLC bought a new position in Clorox in the 4th quarter valued at $31,000. Asset Planning Inc purchased a new stake in shares of Clorox during the 4th quarter valued at $32,000. Finally, Halbert Hargrove Global Advisors LLC bought a new stake in shares of Clorox during the 4th quarter worth $36,000. 78.53% of the stock is owned by institutional investors.
Clorox Price Performance
Shares of NYSE:CLX opened at $141.80 on Wednesday. The company has a 50 day moving average of $152.23 and a 200 day moving average of $159.43. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The stock has a market cap of $17.47 billion, a P/E ratio of 38.74, a P/E/G ratio of 2.62 and a beta of 0.45.
Clorox Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a yield of 3.44%. Clorox’s payout ratio is presently 133.33%.
Analysts Set New Price Targets
Several equities analysts recently weighed in on the stock. Evercore ISI increased their price target on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Royal Bank of Canada restated a “sector perform” rating and set a $150.00 price target on shares of Clorox in a research note on Thursday, January 30th. JPMorgan Chase & Co. upped their price objective on Clorox from $171.00 to $173.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. Barclays raised their target price on Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research report on Wednesday, February 5th. Finally, StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Three investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $159.62.
Check Out Our Latest Stock Analysis on Clorox
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
- Five stocks we like better than Clorox
- About the Markup Calculator
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- Earnings Per Share Calculator: How to Calculate EPS
- NVIDIA Insiders Sell: This Is What It Means for the MarketĀ
- How to Invest in the FAANG Stocks
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.